Vaccine effectiveness of the BNT162b2 mRNA COVID-19 vaccine against RT-PCR confirmed SARS-CoV-2 infections, hospitalisations and mortality in prioritised risk groups
Hanne-Dorthe Emborg, Palle Valentiner-Branth, Astrid Blicher Schelde, Katrine Finderup Nielsen, Mie Agermose Gram, Ida Rask Moustsen-Helms, Manon Chaine, Ulla Holten Seidelin, Jens Nielsen
doi: https://doi.org/10.1101/2021.05.27.21257583
Hanne-Dorthe Emborg
1Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, 5 Artillerivej 2300 Copenhagen, Denmark
Palle Valentiner-Branth
1Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, 5 Artillerivej 2300 Copenhagen, Denmark
Astrid Blicher Schelde
1Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, 5 Artillerivej 2300 Copenhagen, Denmark
Katrine Finderup Nielsen
1Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, 5 Artillerivej 2300 Copenhagen, Denmark
Mie Agermose Gram
1Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, 5 Artillerivej 2300 Copenhagen, Denmark
Ida Rask Moustsen-Helms
1Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, 5 Artillerivej 2300 Copenhagen, Denmark
Manon Chaine
2Data Integration and Analysis, Statens Serum Institut, 5 Artillerivej 2300 Copenhagen, Denmark
Ulla Holten Seidelin
2Data Integration and Analysis, Statens Serum Institut, 5 Artillerivej 2300 Copenhagen, Denmark
Jens Nielsen
1Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, 5 Artillerivej 2300 Copenhagen, Denmark
Article usage
Posted June 02, 2021.
Vaccine effectiveness of the BNT162b2 mRNA COVID-19 vaccine against RT-PCR confirmed SARS-CoV-2 infections, hospitalisations and mortality in prioritised risk groups
Hanne-Dorthe Emborg, Palle Valentiner-Branth, Astrid Blicher Schelde, Katrine Finderup Nielsen, Mie Agermose Gram, Ida Rask Moustsen-Helms, Manon Chaine, Ulla Holten Seidelin, Jens Nielsen
medRxiv 2021.05.27.21257583; doi: https://doi.org/10.1101/2021.05.27.21257583
Vaccine effectiveness of the BNT162b2 mRNA COVID-19 vaccine against RT-PCR confirmed SARS-CoV-2 infections, hospitalisations and mortality in prioritised risk groups
Hanne-Dorthe Emborg, Palle Valentiner-Branth, Astrid Blicher Schelde, Katrine Finderup Nielsen, Mie Agermose Gram, Ida Rask Moustsen-Helms, Manon Chaine, Ulla Holten Seidelin, Jens Nielsen
medRxiv 2021.05.27.21257583; doi: https://doi.org/10.1101/2021.05.27.21257583
Subject Area
Subject Areas
- Addiction Medicine (319)
- Allergy and Immunology (622)
- Anesthesia (162)
- Cardiovascular Medicine (2334)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11685)
- Forensic Medicine (10)
- Gastroenterology (691)
- Genetic and Genomic Medicine (3669)
- Geriatric Medicine (345)
- Health Economics (629)
- Health Informatics (2357)
- Health Policy (924)
- Hematology (339)
- HIV/AIDS (769)
- Medical Education (363)
- Medical Ethics (104)
- Nephrology (395)
- Neurology (3425)
- Nursing (193)
- Nutrition (518)
- Oncology (1798)
- Ophthalmology (531)
- Orthopedics (214)
- Otolaryngology (285)
- Pain Medicine (229)
- Palliative Medicine (66)
- Pathology (444)
- Pediatrics (1018)
- Primary Care Research (413)
- Public and Global Health (6077)
- Radiology and Imaging (1251)
- Respiratory Medicine (818)
- Rheumatology (375)
- Sports Medicine (320)
- Surgery (396)
- Toxicology (50)
- Transplantation (171)
- Urology (144)